Viewing Study NCT03410992

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-01-22 @ 2:17 PM
Study NCT ID: NCT03410992
Status: COMPLETED
Last Update Posted: 2025-12-23
First Post: 2018-01-19
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study With a Initial Treatment Period Followed by a Randomized-withdrawal Period to Evaluate the Efficacy and Safety of Bimekizumab in Adult Subjects With Moderate to Severe Chronic Plaque Psoriasis
Sponsor: UCB Biopharma SRL
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Plaque Psoriasis View
None Moderate to Severe Chronic Plaque Psoriasis View
None Psoriatic Arthritis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Bimekizumab View
None PSO View
None Psoriasis View